Email this article MODERN TECHNOLOGIES IN SQUAMOUS-CELL ANAL CANCER RADIOTHERAPY PLANNING AND TREATMENT
- Authors: Tkachev S.I.1, Glebovskaya V.V.1, Yazhgunovich I.P.1, Vodyanik V.V.1
-
Affiliations:
- N.N. Russian Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow
- Issue: Vol 2, No 3 (2013)
- Pages: 50-55
- Section: ORIGINAL REPORTS
- Published: 02.03.2015
- URL: https://onco-surgery.info/jour/article/view/103
- DOI: https://doi.org/10.17650/2220-3478-2013-0-3-50-55
- ID: 103
Cite item
Full Text
Abstract
Squamous-cell anal cancer is a rare disease that requires a comprehensive approach in treatment and skilled professionals. Modern diagnostics is important for rational choice of treatment tactics. Radiotherapy is the cornerstone of sphincter-sparing anal cancer treatment. Radiotherapy dose, volume and duration are the key factors affecting treatment efficacy and toxicity.3D-conformal radiotherapy is a priority treatment allowing exact reproduction of treatment conditions, controlled by OBI (on-board imager) and kV X-Ray and cone-beam CT analysis. Intensity-modulated radiation therapy (IMRT) is a next-generation treatment with improved technologies, allowing better protection of normal tissues.Our experience with 21 squamous-cell anal cancer patients treated with IMRT during Nov 2011 – March 2013 is presented in this article.
About the authors
S. I. Tkachev
N.N. Russian Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: oncovalery@mail.ru
Russian Federation
V. V. Glebovskaya
N.N. Russian Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Author for correspondence.
Email: oncovalery@mail.ru
Russian Federation
I. P. Yazhgunovich
N.N. Russian Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: oncovalery@mail.ru
Russian Federation
V. V. Vodyanik
N.N. Russian Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: oncovalery@mail.ru
Russian Federation
References
Supplementary files
